Medicare Enrolled

Dr. Syed Abdullah Waheed, MD

Pulmonary Disease · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
18300 KATY FWY STE 615, Houston, TX 77094
7134648099
In practice since 2013 (12 years)
NPI: 1306286737 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Waheed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waheed? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Waheed

Dr. Syed Abdullah Waheed is a pulmonary disease in Houston, TX, with 12 years in practice. Based on federal Medicare data, Dr. Waheed performed 915 Medicare services across 621 unique beneficiaries.

Between the years covered by Open Payments, Dr. Waheed received a total of $6,282 from 33 pharmaceutical and/or device companies across 191 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Waheed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 50% volume in TX$ $6,282 industry payments

Medicare Practice Summary

Medicare Utilization ↗
915
Medicare services
Top 50% in TX for pulmonary disease
621
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~76 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Critical care, first 30-74 min211$170$395
Office visit, established patient (20-29 min)144$43$197
Critical care, each additional 30 minutes134$88$203
Hospital follow-up visit, high complexity82$96$190
Office visit, established patient (30-39 min)64$65$210
Hospital follow-up visit, moderate complexity55$60$122
Test to determine lung volumes using sensors48$9$112
Test to examine how well the lungs exchange gases38$7$130
Test to determine lung volumes using gas dilution or washout37$9$71
New patient office visit (45-59 min)23$87$300
Initial hospital admission, high complexity22$135$272
New patient office visit (30-44 min)16$58$200
Test to measure expiratory airflow and volume changes before and after medication administration14$8$145
Test for exercise-induced spasm of lung airways14$24$200
Initial hospital admission, moderate complexity13$98$205
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,282
Total received (2019-2024)
Avg $1,047/year across 6 years
Top 29% in TX for pulmonary disease
33
Companies
191
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,689 (90.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$593 (9.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,223
2023
$1,149
2022
$1,488
2021
$1,402
2020
$717
2019
$303

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pulmonx Corporation
$1,500
Ethicon Inc.
$1,114
GlaxoSmithKline, LLC.
$1,091
INTUITIVE SURGICAL, INC.
$508
Actelion Pharmaceuticals US, Inc.
$314
AstraZeneca Pharmaceuticals LP
$260
Insmed, Inc.
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
GENZYME CORPORATION
$131
Grifols USA, LLC
$120
Regeneron Healthcare Solutions, Inc.
$113
United Therapeutics Corporation
$103
Intuitive Surgical, Inc.
$93
Takeda Pharmaceuticals U.S.A., Inc.
$78
Mylan Specialty L.P.
$77
Mallinckrodt Hospital Products Inc.
$77
Paratek Pharmaceuticals, Inc.
$43
Bayer HealthCare Pharmaceuticals Inc.
$39
Philips Electronics North America Corporation
$35
La Jolla Pharmaceutical Company
$31
Merck Sharp & Dohme LLC
$21
Alnylam Pharmaceuticals Inc.
$20
Genentech USA, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Electromed, Inc.
$18
Advanced Respiratory, Inc
$18
Shire North American Group Inc
$17
Amgen Inc.
$16
Apria Healthcare LLC
$14
Novartis Pharmaceuticals Corporation
$14
Gilead Sciences, Inc.
$14
Philips North America LLC
$13
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 59.0% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · CHARTIS CATHETER · DUPIXENT · Da Vinci Surgical System · EVENITY · FASENRA · GIAPREZA · GLASSIA · Life 2000 Ventilation System · Medela · Monarch Platform · NUCALA · NUZYRA · OFEV · ONPATTRO · OPSUMIT · PULMONX CHARTIS TABLET CONSOLE · Prolastin-C Liquid · SMARTVEST · SRC Und · STIOLTO RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Veklury · XOLAIR · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $687 per 100 Medicare services performed
Looking for a pulmonary disease in Houston?
Compare pulmonary diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
118
Per 100K population
2.5
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Waheed is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Waheed experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Waheed performed 211 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waheed receive payments from pharmaceutical companies?
Yes. Dr. Waheed received a total of $6,282 from 33 companies across 191 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waheed's costs compare to other pulmonary diseases in Houston?
Dr. Waheed's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waheed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →